Clinical Trials Logo

Osteoarthritis, Hip clinical trials

View clinical trials related to Osteoarthritis, Hip.

Filter by:

NCT ID: NCT02694146 Completed - Coxarthrosis Clinical Trials

Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis

COX
Start date: March 2016
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy and safety of platelet rich plasma (PRP) in patients with coxarthrosis who don´t respond to treatment with NSAIDs, compared to treatment with hyaluronic acid (Hylan G-F 20).

NCT ID: NCT02625402 Completed - Knee Osteoarthritis Clinical Trials

Pilot RCT Comparing Effectiveness of Two Decision Aids for Hip and Knee Osteoarthritis

Start date: December 2015
Phase: N/A
Study type: Interventional

This pilot RCT study is to examine the comparative effectiveness of two decision aids for hip and knee osteoarthritis.

NCT ID: NCT02609672 Completed - Clinical trials for Osteoarthritis, Knee

Resilience for Older Workers With OA Through Exercise

Start date: August 2015
Phase: N/A
Study type: Interventional

Exercise is effective at reducing pain while improving physical function. However we do not know if exercise can boost resilience in the workplace, to allow people with osteoarthritis to work as long as they desire. Previous research shows that exercise holds the most promise for helping people enjoy their work because it reduces sick time, reduces pain, and improves productivity. However, little work has examined the effect of exercise for people with arthritis in the workplace. The purpose of the study is to investigate whether exercise improves resilience in the workplace, mobility, fitness, strength, and pain in comparison to no exercise in those with knee and/or hip osteoarthritis.

NCT ID: NCT02609464 Completed - Osteoarthritis, Hip Clinical Trials

The Use of Barbed Sutures in Total Hip Arthroplasty

Start date: December 1, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the role of new barbed suture for closure of wound during total hip arthroplasty in reducing the risk for wound healing problems.

NCT ID: NCT02598700 Completed - Hip Osteoarthritis Clinical Trials

Correlation of Spinopelvic Parameters and Acetabular Cup Orientation

Start date: February 2016
Phase:
Study type: Observational

In total hip arthroplasty, cup anteversion is an important factor in stability. Lewinnek's safe zone and functional anteversion are often used to assess appropriate orientation. However, these approaches do not consider the effect of the spinopelvic chain and lumbar mobility when in the seated position. This study will measure functional anteversion when standing and sitting with patient-specific computer models and define a quantitative relationship between the change in functional anteversion and spinopelvic parameters. This will challenge the historical paradigm of the safe zone and provide a tool to define anteversion based on a patient's mechanics and reduce risk of dislocation.

NCT ID: NCT02577822 Completed - Clinical trials for Osteoarthritis of Hip

The Viability of Short Stems in Total Hip Arthroplasty

Start date: October 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the viability of short femoral stems as an alternative to standard-length stems in total hip arthroplasty.

NCT ID: NCT02562586 Completed - Osteoarthritis, Hip Clinical Trials

Is Drainage Necessary After Total Hip Replacement?

Start date: May 2014
Phase: N/A
Study type: Interventional

The goal of this study was to compare early results of Total Hip Replacement (THR) in 2 groups of patients: with and without closed suction drainage (CSD). Patients were followed for 3 months post operatively.

NCT ID: NCT02528188 Completed - Chronic Pain Clinical Trials

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

Start date: July 21, 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the long-term joint safety and efficacy (pain relief) of the investigational study drug, tanezumab compared to non-steroidal anti inflammatory drugs (NSAIDs) in subjects with osteoarthritis of the hips or knees.

NCT ID: NCT02524197 Completed - Osteoarthritis Clinical Trials

A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee

Start date: August 2015
Phase: Phase 2
Study type: Interventional

To assess the safety and tolerability of orally-administered CR845 in patients with osteoarthritis (OA) of the hip or knee. The study drug is being tested to reduce OA pain, and will be taken twice a day for two weeks, with four different doses (strengths) being tested. From screening period to follow up examination, the study is expected to last for up to 38 days per participant.

NCT ID: NCT02498314 Completed - Hip Osteoarthritis Clinical Trials

Clinical Effects of Translatoric Grades of Movement in Hip Osteoarthritis Patients

Start date: April 2015
Phase: N/A
Study type: Interventional

In orthopaedic manual therapy translatoric grades of movement are used to determine the intensity of force applied during the mobilization. Different clinical effects are described for each translatoric grade of movement but there are not published studies evaluating these clinical effects. The objective of this trial is to determine if force magnitude during hip traction in resting position affects immediate and short-term outcomes (pain, physical function, hip muscle length and hip range of motion) in patients with hip osteoarthritis. For this purpose, investigators conduct a randomized clinical trial, double-blind (patient and physical therapist examiner). Participants entering the study were randomized into 1 of 3 treatment groups: grade I- grade IISZ mobilization, grade IITZ mobilization or grade III mobilization. Participants attend three sessions on alternate days (monday, wednesday, friday) and at the same hour. Measurements are taken prior to treatment, immediately after each session treatment. The participants are recruited from physiotherapy groups or referred by general practitioners and orthopedic surgeons. Participants were assigned to 1 of the 3 study groups through concealed allocation (sealed envelopes) and independent blocked randomization, using a random number generator. One physical therapist enroll patients in the study, while an independent research assistant performed the randomization and prepared the sealed envelopes, which are opened after baseline data collection by the physiotherapist performing the treatments. Participants are treated in a private treatment area and have no knowledge of treatments received by other participants. A second experienced orthopaedic manual therapist applies the standardized hip traction mobilization in resting position at either level of force, during 10 minutes. This amount of mobilization is consistent with clinical practice and previous studies in osteoarthritis patients. Two physiotherapists (third and fourth) with 5 years of experience, who were blinded to participant group, performed all measurements.The outcome measures are pain, physical function, hip muscle length and hip passive range of motion. Pain is registered with visual analogic scale (VAS), Pressure Pain Threshold ( PPT) and WOMAC pain subscale. Physical function is registered using Timed Up & Go test (TUG), the 20-Meter Walking Test (20MWT) and the physical function subscale of WOMAC index. The hip muscle length is measured using Ely´s test, Active Knee Extension test and modified Ober´s test. The passive hip range of motion is measured using inclinometer or goniometer.